Dec 10, 2021 / NTS GMT
Spencer Israel - Benzinga - Moderator
All right, I do see our next speaker here backstage, let's get them on. Look, see, I speak it into existence. Karam Takhar is the Skye Bioscience Vice President of corporate development. There he is, how are we doing today, sir?
Karam Takhar - Skye Bioscience, Inc. - VP for Corporate Development
Good, Spencer. How are you?
Spencer Israel - Benzinga - Moderator
Doing fantastic. Let's see the charts, there they are. All right. The floor is yours, sir.
Karam Takhar - Skye Bioscience, Inc. - VP for Corporate Development
All right. Thanks, Spencer. Thanks to you and the team of Benzinga. Always a pleasure to be here. Again, my name is Karam Takhar and I'm going to share with you how Skye plans to unlock the pharmaceutical potential of cannabinoids.
Okay. So before we get into it, standard legal disclaimer here. I will be making forward-looking statements. For all the risks associated with our business, we do encourage you to look at our
Skye Bioscience Inc at Benzinga Global Small Cap Investor Conference (Virtual) Transcript
Dec 10, 2021
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers